MiMedx Stock Options

MDXG Stock  USD 8.91  0.14  1.55%   
MiMedx's latest option contracts expiring on March 21st 2025 are carrying combined implied volatility of 1.48 with a put-to-call open interest ratio of 1.43 over 14 outstanding agreements suggesting investors are buying way more puts than calls on contracts expiring on March 21st 2025.

Open Interest Against March 21st 2025 Option Contracts

The chart above shows MiMedx's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. MiMedx's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for MiMedx's option, there is no secondary market available for investors to trade.

In The Money vs. Out of Money Option Contracts on MiMedx

Analyzing MiMedx's in-the-money options over time can help investors to take a profitable long position in MiMedx regardless of its overall volatility. This is especially true when MiMedx's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money MiMedx's options could be used as guardians of the underlying stock as they move almost dollar for dollar with MiMedx's stock while costing only a fraction of its price.

MiMedx Group In The Money Call Balance

When MiMedx's strike price is surpassing the current stock price, the option contract against MiMedx Group stock is said to be in the money. When it comes to buying MiMedx's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on MiMedx Group are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

MiMedx Current Options Market Mood

MiMedx's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps MiMedx Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most MiMedx's options investors are not very successful. MiMedx's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current MiMedx contract

Base on the Rule 16, the options market is currently suggesting that MiMedx Group will have an average daily up or down price movement of about 0.0925% per day over the life of the 2025-03-21 option contract. With MiMedx trading at USD 8.91, that is roughly USD 0.008242. If you think that the market is fully incorporating MiMedx's daily price movement you should consider buying MiMedx Group options at the current volatility level of 1.48%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing MiMedx options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" MiMedx calls. Remember, the seller must deliver MiMedx Group stock to the call owner when a call is exercised.

MiMedx Option Chain

When MiMedx's strike price is surpassing the current stock price, the option contract against MiMedx Group stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
MiMedx's option chain is a display of a range of information that helps investors for ways to trade options on MiMedx. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for MiMedx. It also shows strike prices and maturity days for a MiMedx against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
MDXG250321C0000250002.56.1 - 8.44.0In
Call
MDXG250321C00005000175.03.4 - 4.64.6In
Call
MDXG250321C000075001467.51.65 - 2.21.6In
Call
MDXG250321C0001000029610.00.25 - 0.50.4Out
Call
MDXG250321C000125002212.50.0 - 0.30.05Out
Call
MDXG250321C00015000015.00.0 - 0.750.75Out
Call
MDXG250321C00017500017.50.0 - 0.750.75Out
 Put
MDXG250321P0000250002.50.0 - 0.750.75Out
 Put
MDXG250321P000050004485.00.0 - 0.20.3Out
 Put
MDXG250321P00007500867.50.0 - 0.750.4Out
 Put
MDXG250321P0001000015110.00.0 - 1.91.95In
 Put
MDXG250321P00012500112.53.1 - 5.43.47In
 Put
MDXG250321P00015000015.05.6 - 8.18.56In
 Put
MDXG250321P00017500017.57.0 - 10.57.0In

MiMedx Market Cap Over Time

   Market Cap   
       Timeline  

MiMedx Total Stockholder Equity

Total Stockholder Equity

172.33 Million

At this time, MiMedx's Total Stockholder Equity is most likely to increase significantly in the upcoming years.

MiMedx Corporate Management

Matthew NotarianniHead RelationsProfile
Todd NewtonInterim DirectorProfile
William PhelanVP OfficerProfile
Kim MollerChief OfficerProfile
William IVGeneral OfficerProfile
When determining whether MiMedx Group is a strong investment it is important to analyze MiMedx's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact MiMedx's future performance. For an informed investment choice regarding MiMedx Stock, refer to the following important reports:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MiMedx Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MiMedx. If investors know MiMedx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MiMedx listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.1)
Earnings Share
0.57
Revenue Per Share
2.447
Quarterly Revenue Growth
0.029
Return On Assets
0.1838
The market value of MiMedx Group is measured differently than its book value, which is the value of MiMedx that is recorded on the company's balance sheet. Investors also form their own opinion of MiMedx's value that differs from its market value or its book value, called intrinsic value, which is MiMedx's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MiMedx's market value can be influenced by many factors that don't directly affect MiMedx's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MiMedx's value and its price as these two are different measures arrived at by different means. Investors typically determine if MiMedx is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MiMedx's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.